Association Between Early Sjögren Markers and Symptoms and Signs of Dry Eye.


Journal

Cornea
ISSN: 1536-4798
Titre abrégé: Cornea
Pays: United States
ID NLM: 8216186

Informations de publication

Date de publication:
Mar 2020
Historique:
pubmed: 22 10 2019
medline: 19 12 2020
entrez: 22 10 2019
Statut: ppublish

Résumé

Animal models suggest that early markers of Sjögren syndrome (EMS)-antibodies against salivary protein 1, parotid secretory protein, and carbonic anhydrase 6 (CA6)-are more accurate signals of early Sjögren when compared with classic markers (anti-Ro and anti-La). To further understand the relationship between EMS and dry eye (DE), we compared symptoms and signs of DE in subjects who tested positive versus negative for EMS. In this cross-sectional study, patients at the Miami Veterans Affairs Eye Clinic who were tested for EMS underwent a standard ocular surface examination. Indications for EMS testing included DE symptoms in combination with dry mouth symptoms, low tear production, corneal staining, or a Sjögren disease-associated autoimmune disease. Statistical tests performed were the χ test, Fisher exact test, independent sample t test, and Spearman correlation. Seventy-three percent of 44 patients tested positive for 1 or more EMS. CA6 IgG was most frequently elevated, followed by CA6 IgM and parotid secretory protein IgG. EMS-positive versus EMS-negative subjects were more likely to escalate DE treatment past artificial tears to topical cyclosporine (n = 32, 100% vs. n = 9, 75%, P = 0.02). There were no demographic or comorbidity differences between EMS-positive and EMS-negative subjects, and marker levels did not correlate with more severe tear film measures. Most of the individuals with DE tested positive for 1 or more EMS antibodies, including men and Hispanics. Future studies will be needed to understand how to incorporate EMS data into the care of an individual with DE.

Identifiants

pubmed: 31634227
doi: 10.1097/ICO.0000000000002171
pmc: PMC7007845
mid: NIHMS1538674
pii: 00003226-202003000-00007
doi:

Substances chimiques

Antibodies, Antinuclear 0
BPIFA2 protein, human 0
Biomarkers 0
Ribonucleoproteins 0
SS-A antigen 0
SS-B antibodies 0
Salivary Proteins and Peptides 0
Carbonic Anhydrases EC 4.2.1.1
carbonic anhydrase VI EC 4.2.1.1

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

311-315

Subventions

Organisme : BLRD VA
ID : I01 BX004893
Pays : United States
Organisme : CSRD VA
ID : I01 CX001089
Pays : United States
Organisme : NEI NIH HHS
ID : P30 EY014801
Pays : United States
Organisme : NEI NIH HHS
ID : R01 EY026174
Pays : United States

Références

BMC Ophthalmol. 2015 Apr 10;15:38
pubmed: 25881294
Arthritis Care Res (Hoboken). 2019 Jul;71(7):949-960
pubmed: 30044541
Arthritis Care Res (Hoboken). 2012 Apr;64(4):475-87
pubmed: 22563590
Arthritis Rheum. 2009 May 15;61(5):711-4
pubmed: 19405009
Cont Lens Anterior Eye. 2010 Apr;33(2):55-60
pubmed: 20093066
J Immunol. 2013 Jul 15;191(2):608-13
pubmed: 23772034
Clin Immunol. 2018 Mar;188:58-63
pubmed: 29292085
Cornea. 2018 Nov;37(11):1425-1430
pubmed: 30161055
Am J Ophthalmol. 2015 Sep;160(3):447-452.e1
pubmed: 26093285
Ocul Surf. 2017 Jul;15(3):539-574
pubmed: 28736342
Am Fam Physician. 2009 Mar 15;79(6):465-70
pubmed: 19323359
Am J Physiol. 1997 Apr;272(4 Pt 1):G863-71
pubmed: 9142919
Open Rheumatol J. 2017 Jan 31;11:10-15
pubmed: 28400867
Arthritis Rheumatol. 2017 Jan;69(1):35-45
pubmed: 27785888
J Histochem Cytochem. 2002 Jun;50(6):821-7
pubmed: 12019298
Clin Exp Immunol. 2007 May;148(2):281-7
pubmed: 17286756
J Immunol Res. 2019 Jan 13;2019:7935451
pubmed: 30766890
Clin Immunol. 2014 Nov;155(1):42-46
pubmed: 25178982
Clin Immunol. 2012 Dec;145(3):251-5
pubmed: 23123440
BMC Ophthalmol. 2017 Mar 7;17(1):20
pubmed: 28270126
Biol Sex Differ. 2017 May 12;8:16
pubmed: 28507729
BMJ. 1998 Apr 18;316(7139):1236-8
pubmed: 9553006
J Histochem Cytochem. 1990 Jul;38(7):941-7
pubmed: 2113069
Biochem Genet. 1989 Oct;27(9-10):613-37
pubmed: 2482730
Arthritis Care Res (Hoboken). 2014 Mar;66(3):454-63
pubmed: 23983119
Ann Rheum Dis. 2014 May;73(5):861-70
pubmed: 23572339
Arch Ophthalmol. 2000 May;118(5):615-21
pubmed: 10815152
J Med Case Rep. 2014 May 11;8:145
pubmed: 24885364
Invest Ophthalmol Vis Sci. 2015 May;56(5):2867-71
pubmed: 26024073
Ann Rheum Dis. 2002 Jun;61(6):554-8
pubmed: 12006334
Clin Immunol. 2009 Mar;130(3):304-12
pubmed: 19038581
Subcell Biochem. 2014;75:9-30
pubmed: 24146372
Am J Ophthalmol Case Rep. 2017 Oct 06;8:48-52
pubmed: 29260117
Science. 2002 Nov 15;298(5597):1395-401
pubmed: 12376594
Clin Rheumatol. 2008 Dec;27(12):1479-83
pubmed: 18553114
Clin Ophthalmol. 2016 Jul 20;10:1329-34
pubmed: 27499612

Auteurs

Sasha Hubschman (S)

Department of Ophthalmology, Miami Veterans Administration Medical Center, Miami, FL; and.
Department of Ophthalmology, Bascom Palmer Eye Institute, Miller School of Medicine, Miami, FL.

Mario Rojas (M)

Department of Ophthalmology, Miami Veterans Administration Medical Center, Miami, FL; and.
Department of Ophthalmology, Bascom Palmer Eye Institute, Miller School of Medicine, Miami, FL.

Meghana Kalavar (M)

Department of Ophthalmology, Miami Veterans Administration Medical Center, Miami, FL; and.
Department of Ophthalmology, Bascom Palmer Eye Institute, Miller School of Medicine, Miami, FL.

Amy Kloosterboer (A)

Department of Ophthalmology, Miami Veterans Administration Medical Center, Miami, FL; and.
Department of Ophthalmology, Bascom Palmer Eye Institute, Miller School of Medicine, Miami, FL.

Alfonso L Sabater (AL)

Department of Ophthalmology, Bascom Palmer Eye Institute, Miller School of Medicine, Miami, FL.

Anat Galor (A)

Department of Ophthalmology, Miami Veterans Administration Medical Center, Miami, FL; and.
Department of Ophthalmology, Bascom Palmer Eye Institute, Miller School of Medicine, Miami, FL.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH